Stay updated on CSL312 Safety and Efficacy in HAE Prophylaxis Clinical Trial
Sign up to get notified when there's something new on the CSL312 Safety and Efficacy in HAE Prophylaxis Clinical Trial page.

Latest updates to the CSL312 Safety and Efficacy in HAE Prophylaxis Clinical Trial page
- CheckyesterdayChange DetectedThe page displays a new Revision: v3.3.3 and removes the HHS Vulnerability Disclosure link as well as the previous Revision: v3.3.2 reference. These changes are limited to page revision metadata and footer links, not to core study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision history now shows an added entry for Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoved the site-wide government operating status/funding notice from the page. This is a non-content housekeeping change; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedNew history entries with recent dates were added to the Record History. The page layout remains the same.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference8%

- Check86 days agoChange Detected- Version revision updated from v3.0.2 to v3.1.0, signaling a new release.SummaryDifference0.2%

Stay in the know with updates to CSL312 Safety and Efficacy in HAE Prophylaxis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL312 Safety and Efficacy in HAE Prophylaxis Clinical Trial page.